Press Releases Press Releases Year None2021202020192018 Date Title September 9, 2021 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference September 8, 2021 InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study July 13, 2021 InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete HDE Submission July 6, 2021 InVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021 March 12, 2021 InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 5, 2021 InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference February 16, 2021 InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine Invivo - Investor Tools Print Page Email Alerts RSS Feeds Contact IR
Press Releases Year None2021202020192018 Date Title September 9, 2021 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference September 8, 2021 InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study July 13, 2021 InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete HDE Submission July 6, 2021 InVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021 March 12, 2021 InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 5, 2021 InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference February 16, 2021 InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine
